Home > Insider Trading > Filing (0001179110-10-003917)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158223	Affymax Inc	AFFY	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1376797	B Paul Cleveland	C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304	Evp, Corp. Development And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-02-25	52,935	$4.36	55,935	No	4	M	Direct
Common Stock	Disposition	2010-02-25	52,761	$18.29	3,174	No	4	S	Direct
Common Stock	Disposition	2010-02-25	3,089	$19.02	85	No	4	S	Direct
Common Stock	Disposition	2010-02-25	85	$19.15	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2010-02-25	52,935	$0.00	52,935	$4.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
59,837		2016-02-06	No	4	M	Direct

Footnotes

Includes shares acquired pursuant to the issuer's employee stock purchase plan.
Shares were sold pursuant to a 10b5-1 plan.
The shares were sold at prices between $17.98 and $18.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each price.
The shares subject to the option are exercisable upon grant. Twenty-Five Percent of the shares subject to the option vest one year from the date of grant and the remainder vest in equal monthly installments over the following three years.